May 21 (Reuters) - Keros Therapeutics Inc KROS.O:
ADAR1 CAPITAL MANAGEMENT - ISS RECOMMENDS WITHHOLDING VOTES FROM KEROS THERAPEUTICS DIRECTORS MARY ANN GRAY & ALPNA SETH AT ANNUAL MEETING
Source text: ID:nPndnHgBa
Further company coverage: KROS.O
((Reuters.Briefs@thomsonreuters.com;))